Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Mallinckrodt
Accenture
Moodys
Fish and Richardson
Colorcon
Farmers Insurance
McKinsey

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,776,015

« Back to Dashboard

Which drugs does patent 7,776,015 protect, and when does it expire?

Patent 7,776,015 protects OTREXUP and is included in one NDA.

This patent has thirteen patent family members in eight countries.
Summary for Patent: 7,776,015
Title:Needle assisted jet injector
Abstract: A jet injection device with a fluid chamber in a housing member for holding about 0.02 ml to about 3 ml of a medicament. An injection-assisting needle has an injection end that extends from the housing for inserting into a patient to a depth of up to about 5 mm. A force-generating source is configured to apply a pressure reaching about 100-1000 psi to the medicament in the chamber to expel the medicament through the injecting end of the needle.
Inventor(s): Sadowski; Peter L. (Woodbury, MN), Deboer; David M. (Brighton, MI), Berman; Claude L. (Ypsilanti, MI), Lesch, Jr.; Paul R. (Lexington, MI), Holland; Margaret L. (Rochester, NY)
Assignee: Antares Pharma Inc. (Minneapolis, MN)
Application Number:11/002,687
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 7,776,015

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-001 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-002 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-003 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-004 Oct 11, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,776,015

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,428,528 Needle assisted jet injector ➤ Sign Up
7,744,582 Needle assisted jet injector ➤ Sign Up
RE44846 Needle assisted jet injector ➤ Sign Up
RE44847 Needle assisted jet injector ➤ Sign Up
6,565,553 Needle assisted jet injector ➤ Sign Up
6,746,429 Needle assisted jet injector ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,776,015

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 4299466 ➤ Sign Up
Japan 2002522171 ➤ Sign Up
Spain 2229183 ➤ Sign Up
European Patent Office 1336419 ➤ Sign Up
European Patent Office 1104317 ➤ Sign Up
Germany 69921704 ➤ Sign Up
Germany 69908140 ➤ Sign Up
China 1212867 ➤ Sign Up
China 1323230 ➤ Sign Up
Australia 5470499 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Boehringer Ingelheim
Fuji
Express Scripts
Cerilliant
McKinsey
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot